{"&cites=6477801428873898453&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","url":"https://ard.bmj.com/content/73/3/492.short","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé FC Breedveld…"],"year":2014,"numCitations":2331,"pdf":"https://ard.bmj.com/content/annrheumdis/73/3/492.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15630718529220191090&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ciNJ7q9369gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15630718529220191090&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com","p":1,"exp":1596893543825},{"title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update","url":"https://ard.bmj.com/content/76/6/960.abstract","authors":["JS Smolen","JS Smolen R Landewé","JS Smolen R Landewé J Bijlsma…"],"year":2017,"numCitations":1810,"pdf":"http://eprints.whiterose.ac.uk/116927/1/annrheumdis-2016-210715.pdf","citationUrl":"http://scholar.google.com/scholar?cites=532213958404936786&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:UhQ7f8bNYgcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=532213958404936786&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force","url":"https://ard.bmj.com/content/77/1/3.abstract","authors":["JS Smolen","JS Smolen M Schöls","JS Smolen M Schöls J Braun","JS Smolen M Schöls J Braun M Dougados…"],"year":2018,"numCitations":283,"pdf":"https://ard.bmj.com/content/annrheumdis/77/1/3.full.pdf","citationUrl":"http://scholar.google.com/scholar?cites=6836201155274439746&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:Qnw_IbsQ314J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=6836201155274439746&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"2016 update of the EULAR recommendations for the management of early arthritis","url":"https://ard.bmj.com/content/76/6/948?papetoc=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=ARD_TrendMD-0","authors":["B Combe","B Combe R Landewe","B Combe R Landewe CI Daien","B Combe R Landewe CI Daien C Hua…"],"year":2017,"numCitations":268,"pdf":"https://ard.bmj.com/content/76/6/948?papetoc=&utm_source=TrendMD&utm_medium=cpc&utm_campaign=ARD_TrendMD-0","citationUrl":"http://scholar.google.com/scholar?cites=17075997962203129507&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:o2Zpkqwh-uwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17075997962203129507&hl=en&as_sdt=2005&sciodt=0,5","publication":"ard.bmj.com"},{"title":"JAK inhibition as a therapeutic strategy for immune and inflammatory diseases","url":"https://www.nature.com/articles/nrd.2017.201/","authors":["DM Schwartz","DM Schwartz Y Kanno","DM Schwartz Y Kanno A Villarino","DM Schwartz Y Kanno A Villarino M Ward…"],"year":2017,"numCitations":281,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168198/","citationUrl":"http://scholar.google.com/scholar?cites=11022448766269290018&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:InZs5MCa95gJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=11022448766269290018&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study","url":"https://www.bmj.com/content/357/bmj.j1415","authors":["AK Waljee","AK Waljee MAM Rogers","AK Waljee MAM Rogers P Lin","AK Waljee MAM Rogers P Lin AG Singal","AK Waljee MAM Rogers P Lin AG Singal JD Stein…"],"year":2017,"numCitations":235,"pdf":"https://www.bmj.com/content/357/bmj.j1415","citationUrl":"http://scholar.google.com/scholar?cites=7005454326452706974&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nt5v6pdfOGEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7005454326452706974&hl=en&as_sdt=2005&sciodt=0,5","publication":"bmj.com"},{"title":"The emerging safety profile of JAK inhibitors in rheumatic disease","url":"https://www.nature.com/nrrheum/journal/v13/n4/full/nrrheum.2017.23.html","authors":["KL Winthrop"],"year":2017,"numCitations":232,"citationUrl":"http://scholar.google.com/scholar?cites=18017109658952318708&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:9L4crcahCfoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=18017109658952318708&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Novel treatment strategies in rheumatoid arthritis","url":"https://www.sciencedirect.com/science/article/pii/S0140673617314915","authors":["GR Burmester","GR Burmester JE Pope"],"year":2017,"numCitations":229,"citationUrl":"http://scholar.google.com/scholar?cites=460062619552574321&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:cevd1IN4YgYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=460062619552574321&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial","url":"https://www.bmj.com/content/354/bmj.i4205","authors":["EA Haavardsholm","EA Haavardsholm AB Aga","EA Haavardsholm AB Aga IC Olsen","EA Haavardsholm AB Aga IC Olsen S Lillegraven…"],"year":2016,"numCitations":181,"pdf":"https://www.bmj.com/content/354/bmj.i4205","citationUrl":"http://scholar.google.com/scholar?cites=12759344228605822650&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ugb7WPlLErEJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=12759344228605822650&hl=en&as_sdt=2005&sciodt=0,5","publication":"bmj.com"},{"title":"Methotrexate monotherapy and methotrexate combination therapy with traditional and biologic disease modifying anti‐rheumatic drugs for rheumatoid arthritis: A …","url":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010227.pub2/abstract","authors":["GS Hazlewood","GS Hazlewood C Barnabe…"],"year":2016,"numCitations":178,"pdf":"https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010227.pub2/pdf/CDSR/CD010227/CD010227_standard.pdf","citationUrl":"http://scholar.google.com/scholar?cites=14894651886729566281&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:SRieyflutM4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14894651886729566281&hl=en&as_sdt=2005&sciodt=0,5","publication":"cochranelibrary.com"}]}